Theragen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 181

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Theragen General Information

Description

Developer of a bone stimulation device intended for body healing and pain relief. The company's technology delivers a bone growth stimulator system by combining all-day wearability, proven capacitive coupling therapy, and automated daily clinical data capture to engage patients, enable compliance, and generate insight reports to inform clinicians when patients need guidance to stay on their healing journey, enabling patients to get relief from various kinds of pain and live a healthy life.

Contact Information

Website
www.actastim.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10151 Deerwood Park Boulevard
  • Building 400, Suite 100
  • Jacksonville, FL 32256
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Wearables & Quantified Self, HealthTech, Mobile
Corporate Office
  • 10151 Deerwood Park Boulevard
  • Building 400, Suite 100
  • Jacksonville, FL 32256
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theragen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Nov-2025 Completed Generating Revenue
2. Debt - PPP 15-Apr-2020 Completed Generating Revenue
1. Early Stage VC (Series A1) 21-Jun-2017 $10.4M $10.4M Completed Generating Revenue
To view Theragen’s complete valuation and funding history, request access »

Theragen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Theragen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Theragen Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Theragen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260273277-A1 Devices and methods for monitoring use of a therapeutic device Pending 05-Feb-2021
US-20260151626-A1 Electrical stimulation devices with integrated motion and impedance sensing Pending 05-Feb-2021
US-20260124447-A1 Methods for promoting post-surgical healing and devices for same Pending 05-Feb-2021
US-20260151627-A1 Systems and methods for enhancing bone healing Pending 05-Feb-2021
EP-4288138-B1 Systems for electrical stimulation therapy Active 05-Feb-2021 A61N1/36031
To view Theragen’s complete patent history, request access »

Theragen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theragen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
K2 HealthVentures Venture Capital Minority
Ballast Point Partners Growth/Expansion Minority
To view Theragen’s complete investors history, request access »

Theragen Acquisitions (1)

Theragen’s most recent deal was a Merger/Acquisition with Neurotech North America. The deal was made on 18-Aug-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Neurotech North America 18-Aug-2015 Merger/Acquisition Therapeutic Devices
To view Theragen’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Theragen FAQs

  • When was Theragen founded?

    Theragen was founded in 2014.

  • Where is Theragen headquartered?

    Theragen is headquartered in Jacksonville, FL.

  • What is the size of Theragen?

    Theragen has 181 total employees.

  • What industry is Theragen in?

    Theragen’s primary industry is Therapeutic Devices.

  • Is Theragen a private or public company?

    Theragen is a Private company.

  • What is Theragen’s current revenue?

    The current revenue for Theragen is .

  • How much funding has Theragen raised over time?

    Theragen has raised $10.4M.

  • Who are Theragen’s investors?

    K2 HealthVentures and Ballast Point Partners have invested in Theragen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process